Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 9/20 | 0.37 |
| ▸ | GLP1R | P43220 | 8/20 | 0.33 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25944862 | 0.89 | ALB (0.36) | ALBGLP1RSIRT5 | |
| SCHEMBL26346638 | 0.84 | GLP1R (0.40) | ALBGLP1R | |
| SCHEMBL26225768 | 0.84 | ALB (0.33) | ALB | |
| SCHEMBL8119857 | 0.82 | GLP1R (0.44) | ALBGLP1RSIRT5 | |
| SCHEMBL25944453 | 0.80 | ALB (0.33) | ALB | |
| SCHEMBL29328700 | 0.79 | TSHR (0.35) | — | |
| SCHEMBL24630340 | 0.79 | GLP1R (0.49) | ALBGLP1R | |
| SCHEMBL29072106 | 0.79 | GLP1R (0.49) | ALBGLP1R | |
| SCHEMBL24629997 | 0.78 | CASP2 (0.49) | — | |
| SCHEMBL26346640 | 0.78 | GLP1R (0.35) | GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024054870-A1 | USE OF IL-7R-ALPHA-GAMMA AGONIST PEPTIDES IN CELL MANUFACTURING | MEDIKINE, INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| US-20230357358-A1 | IL-7R-ALPHA-GAMMA BINDING COMPOUNDS | BLUEBIRD VENTURES I, L.P. | 2023-11-09 | — | — | US | disclosed |
| US-11746139-B2 | IL-7Rαγc binding compounds | MEDIKINE, INC. (US) | 2023-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11746139-B2 | IL-7Rαγc binding compounds | IL2RA, IL23R, IL6ST | ALB 2633/4885GLP1R 287/4885SIRT5 2944/4885 |
| US-20230357358-A1 | IL-7R-ALPHA-GAMMA BINDING COMPOUNDS | IL2RA, IL2, IL6ST | ALB 1918/4885GLP1R 266/4885SIRT5 2909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.